Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2013, Article ID 350519, 13 pages
http://dx.doi.org/10.1155/2013/350519
Research Article

Prenylated Flavonoids from Morus alba L. Cause Inhibition of G1/S Transition in THP-1 Human Leukemia Cells and Prevent the Lipopolysaccharide-Induced Inflammatory Response

1Department of Human Pharmacology and Toxicology, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences Brno, Palackého 1-3, 612 42 Brno, Czech Republic
2Department of Histology and Embryology, Faculty of Medicine, Masaryk University, Kamenice 3, 625 00 Brno, Czech Republic
3Department of Natural Drugs, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences Brno, Palackého 1-3, 612 42 Brno, Czech Republic
4Department of Cytokinetics, Institute of Biophysics, Academy of Sciences of the Czech Republic, v.v.i., Královopolská 135, 612 65 Brno, Czech Republic
5International Clinical Research Center, St. Anne’s University Hospital, Pekařská 53, 656 91 Brno, Czech Republic
6Nature Conservation Center, American University of Beirut, P.O. Box 11-0236, Beirut 1107 2020, Lebanon
7Department of Biology, Faculty of Arts and Sciences, American University of Beirut, P.O. Box 11-0236, Beirut 1107 2020, Lebanon

Received 26 March 2013; Accepted 26 April 2013

Academic Editor: Thomas Efferth

Copyright © 2013 Peter Kollar et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Ercisli and E. Orhan, “Chemical composition of white (Morus alba), red (Morus rubra) and black (Morus nigra) mulberry fruits,” Food Chemistry, vol. 103, no. 4, pp. 1380–1384, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. J. Hošek, M. Bartos, S. Chudík et al., “Natural compound cudraflavone B shows promising anti-inflammatory properties in vitro,” Journal of Natural Products, vol. 74, no. 4, pp. 614–619, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. H. Y. Sohn, K. H. Son, C. S. Kwon, G. S. Kwon, and S. S. Kang, “Antimicrobial and cytotoxic activity of 18 prenylated flavonoids isolated from medicinal plants: Morus alba L., Morus mongolica Schneider, Broussnetia papyrifera (L.) Vent, Sophora flavescens Ait and Echinosophora koreensis Nakai,” Phytomedicine, vol. 11, no. 7-8, pp. 666–672, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. J. Du, Z. D. He, R. W. Jiang et al., “Antiviral flavonoids from the root bark of Morus alba L.,” Phytochemistry, vol. 62, no. 8, pp. 1235–1238, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. H. A. El-Beshbishy, A. N. B. Singab, J. Sinkkonen et al., “Hypolipidemic and antioxidant effects of Morus alba L. (Egyptian mulberry) root bark fractions supplementation in cholesterol-fed rats,” Life Sciences, vol. 78, no. 23, pp. 2724–2733, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. H. Oh, E. K. Ko, J. Y. Jun et al., “Hepatoprotective and free radical scavenging activities of prenylflavonoids, coumarin, and stilbene from Morus alba,” Planta Medica, vol. 68, no. 10, pp. 932–934, 2002. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Y. Nam, H. K. Yi, J. C. Lee et al., “Cortex mori extract induces cancer cell apoptosis through inhibition of microtubule assembly,” Archives of Pharmacal Research, vol. 25, no. 2, pp. 191–196, 2002. View at Google Scholar · View at Scopus
  8. N. T. Dat, P. T. X. Binh, L. T. P. Quynh et al., “Cytotoxic prenylated flavonoids from Morus alba,” Fitoterapia, vol. 81, no. 8, pp. 1224–1227, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. J. C. Lee, S. J. Won, C. L. Chao et al., “Morusin induces apoptosis and suppresses NF-κB activity in human colorectal cancer HT-29 cells,” Biochemical and Biophysical Research Communications, vol. 372, no. 1, pp. 236–242, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. T. Kikuchi, M. Nihei, H. Nagai et al., “Albanol A from the root bark of Morus alba L. induces apoptotic cell death in HL60 human leukemia cell line,” Chemical & Pharmaceutical Bulletin, vol. 58, no. 4, pp. 568–571, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Mantovani, P. Allavena, A. Sica, and F. Balkwill, “Cancer-related inflammation,” Nature, vol. 454, no. 7203, pp. 436–444, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. Y. Wu and B. P. Zhou, “TNF-α/NFκB/Snail pathway in cancer cell migration and invasion,” British Journal of Cancer, vol. 102, no. 4, pp. 639–644, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. S. P. Hussain and C. C. Harris, “Inflammation and cancer: an ancient link with novel potentials,” International Journal of Cancer, vol. 121, no. 11, pp. 2373–2380, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. K. Šmejkal, J. Svačinová, T. Šlapetová et al., “Cytotoxic activities of several geranyl-substituted flavanones,” Journal of Natural Products, vol. 73, no. 4, pp. 568–572, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. P. Kollár, T. Bárta, V. Závalová, K. Šmejkal, and A. Hampl, “Geranylated flavanone tomentodiplacone B inhibits proliferation of human monocytic leukaemia (THP-1) cells,” British Journal of Pharmacology, vol. 162, no. 7, pp. 1534–1541, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. B. Safieh-Garabedian, G. M. Mouneimne, W. El-Jouni, M. Khattar, and R. Talhouk, “The effect of endotoxin on functional parameters of mammary CID-9 cells,” Reproduction, vol. 127, no. 3, pp. 397–406, 2004. View at Google Scholar · View at Scopus
  17. K. Pencikova, P. Kollar, V. Muller Zavalova, E. Taborska, J. Urbanova et al., “Investigation of sanguinarine and chelerythrine effects on LPS-induced inflammatory gene expression in THP-1 cell line,” Phytomedicine, vol. 19, pp. 890–895, 2012. View at Publisher · View at Google Scholar
  18. K. A. Klein, R. E. Reiter, J. Redula et al., “Progression of metastatic human prostate cancer to androgen independence in immunodeficient SCID mice,” Nature Medicine, vol. 3, no. 4, pp. 402–408, 1997. View at Publisher · View at Google Scholar · View at Scopus
  19. S. W. Hayward, R. Dahiya, G. R. Cunha, J. Bartek, N. Deshpande, and P. Narayan, “Establishment and characterization of an immortalized but non-transformed human prostate epithelial cell line: BPH-1,” In Vitro Cellular & Developmental Biology, vol. 31, no. 1, pp. 14–24, 1995. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Ghantous, H. Gali-Muhtasib, H. Vuorela, N. A. Saliba, and N. Darwiche, “What made sesquiterpene lactones reach cancer clinical trials?” Drug Discovery Today, vol. 15, no. 15-16, pp. 668–678, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. S. W. Maalouf, R. S. Talhouk, and F. L. Schanbacher, “Inflammatory responses in epithelia: endotoxin-induced IL-6 secretion and iNOS/NO production are differentially regulated in mouse mammary epithelial cells,” Journal of Inflammation, vol. 7, article 58, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. R. S. Talhouk, J. R. Chin, E. N. Unemori, Z. Werb, and M. J. Bissell, “Proteinases of the mammary gland: developmental regulation in vivo and vectorial secretion in culture,” Development, vol. 112, no. 2, pp. 439–449, 1991. View at Google Scholar
  23. W. L. Xia, S. Spector, L. Hardy et al., “Tumor selective G2/M cell cycle arrest and apoptosis of epithelial and hematological malignancies by BBL22, a benzazepine,” Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 13, pp. 7494–7499, 2000. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Kajstura, H. D. Halicka, J. Pryjma, and Z. Darzynkiewicz, “Discontinuous fragmentation of nuclear DNA during apoptosis revealed by discrete “Sub-G1 ” peaks on DNA content histograms,” Cytometry A, vol. 71, no. 3, pp. 125–131, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. S. N. Naryzhny, “Proliferating cell nuclear antigen: a proteomics view,” Cellular and Molecular Life Sciences, vol. 65, no. 23, pp. 3789–3808, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Los, M. Mozoluk, D. Ferrari et al., “Activation and caspase-mediated inhibition of PARP: a molecular switch between fibroblast necrosis and apoptosis in death receptor signaling,” Molecular Biology of the Cell, vol. 13, no. 3, pp. 978–988, 2002. View at Publisher · View at Google Scholar · View at Scopus
  27. C. A. Dinarello, “Immunological and inflammatory functions of the interleukin-1 family,” Annual Review of Immunology, vol. 27, pp. 519–550, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. M. Karin, “Nuclear factor-κB in cancer development and progression,” Nature, vol. 441, no. 7092, pp. 431–436, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. S. Hollebeeck, T. Raas, N. Piront, Y. J. Schneider, O. Toussaint et al., “Dimethyl sulfoxide (DMSO) attenuates the inflammatory response in the in vitro intestinal Caco-2 cell model,” Toxicology Letters, vol. 206, no. 3, pp. 268–275, 2011. View at Publisher · View at Google Scholar
  30. S. W. Jacob and R. Herschler, “Pharmacology of DMSO,” Cryobiology, vol. 23, no. 1, pp. 14–27, 1986. View at Google Scholar · View at Scopus
  31. N. C. Santos, J. Figueira-Coelho, J. Martins-Silva, and C. Saldanha, “Multidisciplinary utilization of dimethyl sulfoxide: pharmacological, cellular, and molecular aspects,” Biochemical Pharmacology, vol. 65, no. 7, pp. 1035–1041, 2003. View at Publisher · View at Google Scholar · View at Scopus
  32. U. Galderisi, F. P. Jori, and A. Giordano, “Cell cycle regulation and neural differentiation,” Oncogene, vol. 22, no. 33, pp. 5208–5219, 2003. View at Publisher · View at Google Scholar · View at Scopus
  33. A. A. Romani, S. Desenzani, M. M. Morganti, S. La Monica, A. F. Borghetti, and P. Soliani, “Zoledronic acid determines S-phase arrest but fails to induce apoptosis in cholangiocarcinoma cells,” Biochemical Pharmacology, vol. 78, no. 2, pp. 133–141, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. O. Gross, C. J. Thomas, G. Guarda, and J. Tschopp, “The inflammasome: an integrated view,” Immunological Reviews, vol. 243, no. 1, pp. 136–151, 2011. View at Publisher · View at Google Scholar
  35. K. A. D. Sauter, L. J. Wood, J. Wong, M. Iordanov, and B. E. Magun, “Doxorubicin and daunorubicin induce processing and release of interleukin-1β through activation of the NLRP3 inflammasome,” Cancer Biology and Therapy, vol. 11, no. 12, pp. 1008–1016, 2011. View at Publisher · View at Google Scholar · View at Scopus
  36. Z. Travnicek, J. Vanco, J. Hosek, R. Buchtik, and Z. Dvorak, “Cellular responses induced by Cu(II) quinolinonato complexes in human tumor and hepatic cells,” Chemistry Central Journal, vol. 6, article 160, 2012. View at Publisher · View at Google Scholar
  37. G. Galati and P. J. O'Brien, “Potential toxicity of flavonoids and other dietary phenolics: significance for their chemopreventive and anticancer properties,” Free Radical Biology and Medicine, vol. 37, no. 3, pp. 287–303, 2004. View at Publisher · View at Google Scholar · View at Scopus
  38. B. H. Havsteen, “The biochemistry and medical significance of the flavonoids,” Pharmacology & Therapeutics, vol. 96, no. 2-3, pp. 67–202, 2002. View at Publisher · View at Google Scholar · View at Scopus
  39. S. Maneechai, W. De-Eknamkul, K. Umehara, H. Noguchi, and K. Likhitwitayawuid, “Flavonoid and stilbenoid production in callus cultures of Artocarpus lakoocha,” Phytochemistry, vol. 81, pp. 42–49, 2012. View at Google Scholar
  40. K. H. Park, Y. D. Park, J. M. Han et al., “Anti-atherosclerotic and anti-inflammatory activities of catecholic xanthones and flavonoids isolated from Cudrania tricuspidata,” Bioorganic & Medicinal Chemistry Letters, vol. 16, no. 21, pp. 5580–5583, 2006. View at Publisher · View at Google Scholar · View at Scopus
  41. H. J. Lee, D. H. Lyu, U. Koo, K. W. Nam, S. S. Hong et al., “Protection of prenylated flavonoids from mori cortex radicis (Moraceae) against nitric oxide-induced cell death in neuroblastoma SH-SY5Y Cells,” Archives of Pharmacal Research, vol. 35, no. 1, pp. 163–170, 2012. View at Publisher · View at Google Scholar
  42. Z. G. Yang, K. Matsuzaki, S. Takamatsu, and S. Kitanaka, “Inhibitory effects of constituents from Morus alba var. multicaulis on differentiation of 3T3-L1 cells and nitric oxide production in RAW264.7 cells,” Molecules, vol. 16, no. 7, pp. 6010–6022, 2011. View at Publisher · View at Google Scholar · View at Scopus